{
  "id": 3,
  "text": "no capital commitments as at December \n31, 2022 and December 31, 2023 to participate \nin any potential future funding of Normandy \nHadrontherapy SAS. IBA has therefore not accounted for its share of \nthe loss and negative equity of Normandy \nHadrontherapy SAS beyond its value of the \ncapital invested. The following table illustrates the summarized financial information of the associates: (EUR 000) \nDecember 31, 2022 \nDecember 31, 2023 \nInvestment in affiliated companies \nCurrent assets \n31 942 \n28 364 \nNon-current assets \n89 035 \n88 949 \nCurrent liabilities (-) \n-14 505 \n-21 637 \nNon-Current l",
  "similarity_score": 0.7903080536212084,
  "metadata": {
    "filename": "annual_report_text (1).txt",
    "filepath": "input\\annual_report_text (1).txt",
    "chunk_id": 817,
    "start_char_idx": 0,
    "end_char_idx": 0,
    "page": null,
    "section": null
  }
}